Statizoid

Health in Latvia

1,236 indicators covering health for Latvia.

IndicatorLatest Year10-yr change Rank
Neonatal mortality rate - High-income country average rate matched 0.8 2030 down 26.9% 195th
Neonatal mortality rate - SDG target met 0.8 2030 down 26.9% 195th
Under 5 mortality rate - Remains constant 2.5 2030 unchanged 190th
Under 5 mortality rate - Current trends maintained 2.1 2030 down 12.3% 196th
Under 5 mortality rate - High-income country average rate matched 2.1 2030 down 12.3% 196th
Under 5 mortality rate - SDG target met 2.1 2030 down 12.3% 196th
Mortality rate age 10-19 - Remains constant 2.24 2030 down 5.4% 158th
Mortality rate age 10-19 - Current trends maintained 1.97 2030 down 15.1% 162nd
Mortality rate age 10-19 - High-income country average rate matched 1.97 2030 down 15.1% 153rd
Neonatal deaths - Remains constant 15 2030 down 6.2% 176th
Neonatal deaths - Current trends maintained 10 2030 down 33.3% 179th
Neonatal deaths - SDG target met 10 2030 down 33.3% 178th
Under-five deaths - Remains constant 32 2030 down 8.6% 172nd
Under-five deaths - Current trends maintained 27 2030 down 20.6% 173rd
Under-five deaths - SDG target met 27 2030 down 20.6% 173rd
Deaths age 10 to 19 - Remains constant 50 2030 unchanged 160th
Deaths age 10 to 19 - Current trends maintained 41 2030 down 14.6% 163rd
Mortality caused by road traffic injury 8.1 per 100,000 population 2019 down 34.1% 137th
Mortality caused by road traffic injury, female 3.6 per 100,000 female population 2019 down 41.9% 138th
Mortality caused by road traffic injury, male 13.2 per 100,000 male population 2019 down 32.3% 133rd
Countries with birth registration data that are at least 90 percent 1 2024 unchanged 2nd
Life expectancy - Regions 76.4 Years 2024 up 2.6% 41st
Ipv vaccine coverage 98 2024 unchanged 32nd
Number of births in thousands 13.71 2025 down 38.3% 65th
Tb patients living with hiv receiving art 35 2017 up 16.7% 93rd
HIV-positive TB patients on ART (antiretroviral therapy) 70.0% 2017 up 29.6% 125th
Hospital beds 49.47 2023 down 14.7% 25th
Treatment success rate for patients treated for MDR-TB 0.0% 2022 down 100.0% 159th
New leprosy case detection rate per 1 000 000 population 0 2024 — 124th
Treatment success rate: HIV-positive TB cases 60 2016 down 17.8% 118th
Peri-neonatal mortality by age of mother and parity, by NUTS 2 region 90 2023 down 50.8% 26th
Fetal, peri- and neonatal mortality rates by NUTS 2 region of 3.61 2023 down 60.8% 14th
Bladder cancer death rate 3.89 2023 down 16.5% 5th
Cancer death rates by type who db 3.89 2023 down 16.5% 5th
Sex ratio at birth 1.06 2024 down 0.1% 19th
Crude birth rate 6.9 2024 down 36.7% 66th
Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) 99.0% 2025 — 1st
International Health Regulations core capacity scores, SPAR version 50 2025 — 85th
Health statistics - Regions (for 'Developer API') — Crude mortality 14.19 Per 1 000 inhabitants 2024 down 0.2% 3rd
Health status - Regions — Crude mortality rate 14.19 Per 1 000 inhabitants 2024 down 0.2% 3rd
Leprosy registered prevalence rate per 1 000 000 population 0 2024 — 121st
Leprosy - Number of new leprosy cases among children 0 2024 — 69th
Leprosy - Number of cases registered for treatment 0 2024 — 121st
New leprosy child case detection rate (less than 15 years of age) per 0 2024 — 69th
GNI, Atlas method 40.36 billion 2024 up 36.7% 50th
GNI per capita, Atlas method 21,630 2024 up 46.0% 35th
Ipv1 number unvaccinated 337.5 2023 down 21.2% 163rd
Number of reported cases of poliomyelitis by wild poliovirus 0 2023 — 3rd
Age-standardized prevalence of current tobacco use among persons aged 34.6% 2024 down 8.5% 13th
Liver cancer death rate 4.73 2023 up 27.8% 37th
Refugees under the mandate of the UNHCR by country or territory of 49,220 2024 up 29,197.6% 36th
Number of female leprosy new cases 0 2024 — 102nd
National smoking ban: NUMBER OF PLACES SMOKE-FREE 6 2022 up 20.0% 81st
Number of prevalent tuberculosis cases 1,100 2014 down 56.0% 128th
Number of new G2D leprosy cases 0 2024 — 86th
Leprosy - New leprosy cases with G2D rate per 1 000 000 population 0 2024 — 86th
Public health expenditure share gdp 5.24 2025 up 52.4% 36th
Proportion of total government spending on essential services, health 12.1% 2023 up 27.2% 45th
Reported rate of new cervical cancer cases 13.3 2017 up 2.7% 7th
Pancreatic cancer death rate 9.21 2023 up 9.0% 6th